“FDA granted a fast-track review designation for #psilocybin as a treatment for #depression , highlighting the therapeutic potential of psychedelic compounds. In addition, #5meodmt and #dmt demonstrated promise in rapidly alleviating symptoms.…evidence suggests that one or two doses of psychedelic compounds may produce rapid and sustained antidepressant effects” Inhalable Psychedelic 5-MeO-DMT Shows Promise in Treatment-Resistant Depression (2026) https://pubs.acs.org/jmcmar/article/69/16/19541/5338094/Inhalable-Psychedelic-5-MeO-DMT-Shows-Promise-in #mentalhealth